Drug Discovery and Development session icon

Safety Pharmacology for the 21st Century – new technologies and approaches supporting safety and predictivity within drug discovery and development

**This sessions has now been made into a full-day online conference on 30 November 2023.

Find out out more and register now.**

  • Chair(s):

    Helen Prior
    Programme Manager, Drug Development,National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs), London, United Kingdom ,

    Andrea Greiter-Wilke
    SPS Vice President Elect, Roche, Switzerland

  • Session description:

    Advances in Safety Pharmacology for improved risk assessment and translation of cardiovascular and CNS adverse events
    Andrea Greiter-Wilke
    SPS Vice President Elect, Roche, Switzerland

    Innovative models for in vitro detection of seizure
    Dr Kimberley Rockley
    Research Fellow, ApconiX, Alderley Edge, United Kingdom

    Oral communication speaker to be confirmed in 2023.

    Use of computational approaches to identify cardiotoxicity risk
    Maxx Holmes
    Oxford University, United Kingdom

    Integration of multiple endpoints into the same animal model or toxicology studies
    Henk van der Linde
    Principal Scientist, Janssen, Global Toxicology and Safety Pharmacology


03 Jul 2023


9:45 am - 12:10 pm


Go to Top